Haiyi Jiang - Researcher Profile | RDL Research Database

Publications

2 shown

Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma

Tony Mok , Yi‐Long Wu , Sumitra Thongprasert +16 more

Gefitinib is superior to carboplatin-paclitaxel as an initial treatment for pulmonary adenocarcinoma among nonsmokers or former light smokers in East Asia. The presence in the t...

2009 New England Journal of Medicine 8112 citations

Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial

Luis Paz‐Ares , Mikhail Dvorkin , Yuanbin Chen +97 more

2019 The Lancet 2014 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 10,126
Institution: AstraZeneca (Japan)

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0009-0002-8677-6821

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.